1997
DOI: 10.1016/s0895-7061(97)90535-5
|View full text |Cite
|
Sign up to set email alerts
|

Malignant pheochromocytoma, still a therapeutic challenge

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2005
2005
2016
2016

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Combination chemotherapy of cyclophosphamide, vincristine, and dacarbazine or of these three agents with doxorubicin have also been reported as effective in treating malignant pheochromocytoma. [15][16][17] After providing these treatment options to the patient, he decided to undergo external beam radiotherapy for his para-aortic tumours. He has experienced a partial response (25% reduction in size to the radiotherapy), and continues under follow up.…”
Section: Discussionmentioning
confidence: 99%
“…Combination chemotherapy of cyclophosphamide, vincristine, and dacarbazine or of these three agents with doxorubicin have also been reported as effective in treating malignant pheochromocytoma. [15][16][17] After providing these treatment options to the patient, he decided to undergo external beam radiotherapy for his para-aortic tumours. He has experienced a partial response (25% reduction in size to the radiotherapy), and continues under follow up.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies considered that radiotherapy was ineffective as a primary therapy and did not prevent local recurrence. However, radiotherapy achieved control of lymph node and bone metastases (17)(18)(19). Cystectomy and prostatectomy was considered to be the preferred treatment in the present case.…”
Section: Discussionmentioning
confidence: 72%
“…By limiting our search to human studies published in English, a substantial number of publications had to be excluded due to foreign language. Other studies had methodological differences with respect to the particular drugs applied or provided limited imaging data on tumour response; the remaining articles are shown in Table . Apart from the more recent study by Ayala‐Ramirez et al ., it has to be pointed out that the cohorts of these reports were rather small, with a maximum of 18 patients in one study and <60 patients in total.…”
Section: Discussionmentioning
confidence: 99%